200 related articles for article (PubMed ID: 20672321)
1. Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
Tripathi M; Potdar AA; Yamashita H; Weidow B; Cummings PT; Kirchhofer D; Quaranta V
Prostate; 2011 Feb; 71(2):184-96. PubMed ID: 20672321
[TBL] [Abstract][Full Text] [Related]
2. Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression.
Tripathi M; Nandana S; Yamashita H; Ganesan R; Kirchhofer D; Quaranta V
J Biol Chem; 2008 Nov; 283(45):30576-84. PubMed ID: 18784072
[TBL] [Abstract][Full Text] [Related]
3. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration.
Udayakumar TS; Chen ML; Bair EL; Von Bredow DC; Cress AE; Nagle RB; Bowden GT
Cancer Res; 2003 May; 63(9):2292-9. PubMed ID: 12727852
[TBL] [Abstract][Full Text] [Related]
4. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
[TBL] [Abstract][Full Text] [Related]
5. Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II.
Gray K; Elghadban S; Thongyoo P; Owen KA; Szabo R; Bugge TH; Tate EW; Leatherbarrow RJ; Ellis V
Thromb Haemost; 2014 Aug; 112(2):402-11. PubMed ID: 24696092
[TBL] [Abstract][Full Text] [Related]
6. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
Webb SL; Sanders AJ; Mason MD; Jiang WG
Oncol Rep; 2012 Oct; 28(4):1491-7. PubMed ID: 22858929
[TBL] [Abstract][Full Text] [Related]
7. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
8. Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.
Bair EL; Chen ML; McDaniel K; Sekiguchi K; Cress AE; Nagle RB; Bowden GT
Neoplasia; 2005 Apr; 7(4):380-9. PubMed ID: 15967115
[TBL] [Abstract][Full Text] [Related]
9. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
[TBL] [Abstract][Full Text] [Related]
10. Matriptase is involved in ErbB-2-induced prostate cancer cell invasion.
Wu SR; Cheng TS; Chen WC; Shyu HY; Ko CJ; Huang HP; Teng CH; Lin CH; Johnson MD; Lin CY; Lee MS
Am J Pathol; 2010 Dec; 177(6):3145-58. PubMed ID: 20971737
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
[TBL] [Abstract][Full Text] [Related]
14. Deregulated activation of matriptase in breast cancer cells.
Benaud CM; Oberst M; Dickson RB; Lin CY
Clin Exp Metastasis; 2002; 19(7):639-49. PubMed ID: 12498394
[TBL] [Abstract][Full Text] [Related]
15. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.
Ko CJ; Huang CC; Lin HY; Juan CP; Lan SW; Shyu HY; Wu SR; Hsiao PW; Huang HP; Shun CT; Lee MS
Cancer Res; 2015 Jul; 75(14):2949-60. PubMed ID: 26018085
[TBL] [Abstract][Full Text] [Related]
16. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.
Galkin AV; Mullen L; Fox WD; Brown J; Duncan D; Moreno O; Madison EL; Agus DB
Prostate; 2004 Nov; 61(3):228-35. PubMed ID: 15368474
[TBL] [Abstract][Full Text] [Related]
17. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
[TBL] [Abstract][Full Text] [Related]
18. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells.
Kiyomiya K; Lee MS; Tseng IC; Zuo H; Barndt RJ; Johnson MD; Dickson RB; Lin CY
Am J Physiol Cell Physiol; 2006 Jul; 291(1):C40-9. PubMed ID: 16467405
[TBL] [Abstract][Full Text] [Related]
19. Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer.
Sun P; Jiang Z; Chen X; Xue L; Mao X; Ruan G; Song Y; Mustea A
Mol Med Rep; 2016 Aug; 14(2):1465-74. PubMed ID: 27356668
[TBL] [Abstract][Full Text] [Related]
20. Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis.
Warren M; Twohig M; Pier T; Eickhoff J; Lin CY; Jarrard D; Huang W
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):23-30. PubMed ID: 18813126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
